Literature DB >> 15531518

Prolonged mild hyperglycemia induces vagally mediated compensatory increase in C-Peptide secretion in humans.

Karen L Teff1, Raymond R Townsend.   

Abstract

Experimentally induced prolonged hyperglycemia increases insulin release in humans, and in animals has been demonstrated to increase vagal efferent activity. The objective of the present experiment was to determine whether in humans, the compensatory increase in insulin release in response to short-term mild hyperglycemia is mediated by an induction of vagal efferent activity. Lean male subjects (n = 11; body mass index, 23.6 +/- 0.8 kg/m(2)) underwent a frequently sampled iv glucose tolerance test (FSIGT) to determine B cell function and insulin sensitivity. Subjects were then tested under four conditions over 4 months. Subjects were infused for 48 h with either glucose (15% dextrose at 200 mg/m(2).min) or saline (50 ml/h). Three hours after termination of the infusion, an FSIGT was administered in the presence of either saline or atropine (0.4 mg/m(2) bolus: 0.4 mg/m(2).h). Glucose (117 +/- 14 vs. 98 +/- 5 mg/dl) and insulin (49.5 +/- 10 vs. 23 +/- 5 muU/ml) levels were significantly elevated during the 48-h glucose infusion compared with those during saline treatment. Forty-eight-hour glucose infusions increased insulin and C-peptide levels during the FSIGT. When the FSIGT was conducted in the presence of atropine after glucose infusion, C-peptide levels were significantly attenuated during the period of endogenous insulin secretion (0-20 min; 31.8 +/- 13 vs. 39.2 +/- 11.9, atropine vs. no atropine) and exogenous insulin administration [20-40 min; 18.8 +/- 10.8 vs. 31.6 +/- 12.9., atropine vs. no atropine; F(3,9) = 4.99; P < 0.026]. A significant negative correlation was found between the repression of C-peptide by muscarinic blockade and the magnitude of the C-peptide response to the glucose infusion (r = 0.60; P < 0.045). Insulin AUC was not significantly altered by the presence of muscarinic blockade. In summary, we found that prolonged mild hyperglycemia results in a compensatory increase in C-peptide secretion, which is partially mediated by an induction in vagal efferent activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531518     DOI: 10.1210/jc.2003-032094

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

2.  48-h glucose infusion in humans: effect on hormonal responses, hunger and food intake.

Authors:  Karen L Teff; Maja Petrova; Peter J Havel; Raymond R Townsend
Journal:  Physiol Behav       Date:  2007-01-04

3.  Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice.

Authors:  J Levi; F K Huynh; H C Denroche; U H Neumann; M M Glavas; S D Covey; T J Kieffer
Journal:  Diabetologia       Date:  2011-12-28       Impact factor: 10.122

Review 4.  Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

Authors:  Karen L Teff; Sangwon F Kim
Journal:  Physiol Behav       Date:  2011-06-12

Review 5.  Atypical antipsychotic-induced weight gain: insights into mechanisms of action.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 6.  How neural mediation of anticipatory and compensatory insulin release helps us tolerate food.

Authors:  Karen L Teff
Journal:  Physiol Behav       Date:  2011-01-20

7.  Cephalic phase pancreatic polypeptide responses to liquid and solid stimuli in humans.

Authors:  Karen L Teff
Journal:  Physiol Behav       Date:  2009-11-26

8.  Effects of genetic severity on glucose homeostasis in Friedreich ataxia.

Authors:  Charles J Isaacs; Karlla W Brigatti; Olena Kucheruk; Sarah Ratcliffe; Tom Sciascia; Shana E McCormack; Steven M Willi; David R Lynch
Journal:  Muscle Nerve       Date:  2016-08-30       Impact factor: 3.217

9.  The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Regul Pept       Date:  2013-10-29

10.  Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia.

Authors:  Michael R Rickels; Elys M Perez; Amy J Peleckis; Erica Alshehabi; Huong-Lan Nguyen; Darko Stefanovski; Karl Rickels; Karen L Teff
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-19       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.